A detailed history of Simplex Trading, LLC transactions in Incyte Corp stock. As of the latest transaction made, Simplex Trading, LLC holds 28,272 shares of INCY stock, worth $2.05 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
28,272
Previous 18,175 55.55%
Holding current value
$2.05 Million
Previous $1.1 Million 69.66%
% of portfolio
0.07%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$57.33 - $68.61 $578,861 - $692,755
10,097 Added 55.55%
28,272 $1.87 Million
Q2 2024

Jul 25, 2024

BUY
$51.18 - $63.75 $601,109 - $748,743
11,745 Added 182.66%
18,175 $1.1 Million
Q1 2024

Apr 25, 2024

BUY
$56.55 - $66.59 $363,616 - $428,173
6,430 New
6,430 $366,000
Q4 2022

Feb 02, 2023

BUY
$67.18 - $84.11 $28,618 - $35,830
426 New
426 $34,000
Q2 2022

Aug 03, 2022

SELL
$66.18 - $83.18 $29,847 - $37,514
-451 Reduced 45.28%
545 $41,000
Q1 2022

May 02, 2022

SELL
$66.02 - $79.71 $1.78 Million - $2.15 Million
-26,950 Reduced 96.44%
996 $79,000
Q4 2021

Feb 23, 2022

SELL
$63.34 - $74.11 $101,407 - $118,650
-1,601 Reduced 5.42%
27,946 $2.05 Million
Q3 2021

Oct 28, 2021

SELL
$68.67 - $84.02 $6,867 - $8,402
-100 Reduced 0.34%
29,547 $2.48 Million
Q2 2021

Aug 12, 2021

BUY
$79.87 - $87.53 $1.01 Million - $1.11 Million
12,644 Added 74.36%
29,647 $2.49 Million
Q1 2021

Apr 26, 2021

BUY
$76.02 - $100.5 $1.29 Million - $1.71 Million
17,003 New
17,003 $0
Q4 2020

Feb 02, 2021

SELL
$80.74 - $97.7 $221,954 - $268,577
-2,749 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$85.07 - $109.69 $206,379 - $266,107
2,426 Added 751.08%
2,749 $246,000
Q2 2020

Jul 13, 2020

BUY
$74.18 - $108.93 $23,960 - $35,184
323 New
323 $0
Q4 2018

Jan 16, 2019

SELL
$58.5 - $69.94 $909,792 - $1.09 Million
-15,552 Closed
0 $0
Q3 2018

Oct 23, 2018

BUY
$61.75 - $74.23 $960,336 - $1.15 Million
15,552 New
15,552 $1.07 Million
Q2 2018

Jul 30, 2018

SELL
$60.85 - $83.98 $6,085 - $8,398
-100 Closed
0 $0
Q1 2018

Apr 26, 2018

BUY
$83.06 - $100.98 $8,306 - $10,098
100 New
100 $8,000
Q4 2017

Jan 10, 2018

SELL
$93.56 - $116.6 $1.28 Million - $1.59 Million
-13,647 Closed
0 $0
Q3 2017

Oct 25, 2017

BUY
$109.15 - $138.27 $1.49 Million - $1.89 Million
13,647
13,647 $1.59 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.